Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $11.0 million.

  • Phibro Animal Health's Change in Accured Expenses fell 5548.33% to $11.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.3 million, marking a year-over-year decrease of 2512.24%. This contributed to the annual value of $47.2 million for FY2025, which is 28689.8% up from last year.
  • Per Phibro Animal Health's latest filing, its Change in Accured Expenses stood at $11.0 million for Q4 2025, which was down 5548.33% from -$13.7 million recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Change in Accured Expenses peaked at $26.1 million during Q2 2025, and registered a low of -$13.7 million during Q3 2025.
  • For the 5-year period, Phibro Animal Health's Change in Accured Expenses averaged around $2.6 million, with its median value being $165500.0 (2024).
  • In the last 5 years, Phibro Animal Health's Change in Accured Expenses skyrocketed by 135799.46% in 2024 and then tumbled by 28842.22% in 2025.
  • Over the past 5 years, Phibro Animal Health's Change in Accured Expenses (Quarter) stood at $5.2 million in 2021, then rose by 15.57% to $6.0 million in 2022, then skyrocketed by 36.38% to $8.2 million in 2023, then surged by 202.8% to $24.8 million in 2024, then plummeted by 55.48% to $11.0 million in 2025.
  • Its Change in Accured Expenses was $11.0 million in Q4 2025, compared to -$13.7 million in Q3 2025 and $26.1 million in Q2 2025.